+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Type 2 Diabetes Market 2025-2029- Product Image
Type 2 Diabetes Market 2025-2029- Product Image
New

Type 2 Diabetes Market 2025-2029

  • PDF Icon

    Report

  • 221 Pages
  • February 2025
  • Region: Global
  • TechNavio
  • ID: 5351696
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The type 2 diabetes market is forecasted to grow by USD 53.8 billion during 2024-2029, accelerating at a CAGR of 12.2% during the forecast period. The report on the type 2 diabetes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of diabetes, rise in prevalence of obesity and changing lifestyles, and recent product approvals.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The type 2 diabetes market is segmented as below:

By Drug Class

  • Insulin
  • DPP-4 inhibitor
  • GLP-1 receptor agonists
  • SGLT-2 inhibitors
  • Others

By Distribution Channel

  • Retail pharmacies
  • Hospital pharmacies
  • Online pharmacies

By Delivery Mode

  • Oral
  • Injectable
  • Continuous glucose monitoring (CGM)

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing geriatric population as one of the prime reasons driving the type 2 diabetes market growth during the next few years. Also, increase in awareness of diabetes and growing initiatives and innovations in therapies will lead to sizable demand in the market.

The report on the type 2 diabetes market covers the following areas:

  • Type 2 Diabetes Market sizing
  • Type 2 Diabetes Market forecast
  • Type 2 Diabetes Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading type 2 diabetes market vendors that include Amgen Inc., AstraZeneca PLC, Baxter International Inc., Biocon Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Daiichi Sankyo Co. Ltd., DM Pharma Marketing Pvt. Ltd., Eli Lilly and Co., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Practo Technologies Pvt. Ltd., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Tonghua Dongbao Pharmaceutical Co. Ltd. Also, the type 2 diabetes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Delivery Mode
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ billion)
Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Type 2 Diabetes Market 2019 - 2023
Historic Market Size - Data Table on Global Type 2 Diabetes Market 2019 - 2023 ($ billion)
5.2 Drug Class segment analysis 2019 - 2023
Historic Market Size - Drug Class Segment 2019 - 2023 ($ billion)
5.3 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion)
5.4 Delivery Mode segment analysis 2019 - 2023
Historic Market Size - Delivery Mode Segment 2019 - 2023 ($ billion)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
6.1 Impact of AI in the Global Type 2 diabetes Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Drug Class
8.1 Market segments
Chart on Drug Class - Market share 2024-2029 (%)
Data Table on Drug Class - Market share 2024-2029 (%)
8.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
8.3 Insulin - Market size and forecast 2024-2029
Chart on Insulin - Market size and forecast 2024-2029 ($ billion)
Data Table on Insulin - Market size and forecast 2024-2029 ($ billion)
Chart on Insulin - Year-over-year growth 2024-2029 (%)
Data Table on Insulin - Year-over-year growth 2024-2029 (%)
8.4 DPP-4 inhibitor - Market size and forecast 2024-2029
Chart on DPP-4 inhibitor - Market size and forecast 2024-2029 ($ billion)
Data Table on DPP-4 inhibitor - Market size and forecast 2024-2029 ($ billion)
Chart on DPP-4 inhibitor - Year-over-year growth 2024-2029 (%)
Data Table on DPP-4 inhibitor - Year-over-year growth 2024-2029 (%)
8.5 GLP-1 receptor agonists - Market size and forecast 2024-2029
Chart on GLP-1 receptor agonists - Market size and forecast 2024-2029 ($ billion)
Data Table on GLP-1 receptor agonists - Market size and forecast 2024-2029 ($ billion)
Chart on GLP-1 receptor agonists - Year-over-year growth 2024-2029 (%)
Data Table on GLP-1 receptor agonists - Year-over-year growth 2024-2029 (%)
8.6 SGLT-2 inhibitors - Market size and forecast 2024-2029
Chart on SGLT-2 inhibitors - Market size and forecast 2024-2029 ($ billion)
Data Table on SGLT-2 inhibitors - Market size and forecast 2024-2029 ($ billion)
Chart on SGLT-2 inhibitors - Year-over-year growth 2024-2029 (%)
Data Table on SGLT-2 inhibitors - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ billion)
Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Drug Class
Market opportunity by Drug Class ($ billion)
Data Table on Market opportunity by Drug Class ($ billion)
9 Market Segmentation by Distribution Channel
9.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
9.3 Retail pharmacies - Market size and forecast 2024-2029
Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ billion)
Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ billion)
Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
9.4 Hospital pharmacies - Market size and forecast 2024-2029
Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ billion)
Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ billion)
Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
9.5 Online pharmacies - Market size and forecast 2024-2029
Chart on Online pharmacies - Market size and forecast 2024-2029 ($ billion)
Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ billion)
Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ billion)
Data Table on Market opportunity by Distribution Channel ($ billion)
10 Market Segmentation by Delivery Mode
10.1 Market segments
Chart on Delivery Mode - Market share 2024-2029 (%)
Data Table on Delivery Mode - Market share 2024-2029 (%)
10.2 Comparison by Delivery Mode
Chart on Comparison by Delivery Mode
Data Table on Comparison by Delivery Mode
10.3 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ billion)
Data Table on Oral - Market size and forecast 2024-2029 ($ billion)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
10.4 Injectable - Market size and forecast 2024-2029
Chart on Injectable - Market size and forecast 2024-2029 ($ billion)
Data Table on Injectable - Market size and forecast 2024-2029 ($ billion)
Chart on Injectable - Year-over-year growth 2024-2029 (%)
Data Table on Injectable - Year-over-year growth 2024-2029 (%)
10.5 Continuous glucose monitoring (CGM) - Market size and forecast 2024-2029
Chart on Continuous glucose monitoring (CGM) - Market size and forecast 2024-2029 ($ billion)
Data Table on Continuous glucose monitoring (CGM) - Market size and forecast 2024-2029 ($ billion)
Chart on Continuous glucose monitoring (CGM) - Year-over-year growth 2024-2029 (%)
Data Table on Continuous glucose monitoring (CGM) - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Delivery Mode
Market opportunity by Delivery Mode ($ billion)
Data Table on Market opportunity by Delivery Mode ($ billion)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ billion)
Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ billion)
Data Table on US - Market size and forecast 2024-2029 ($ billion)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.10 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ billion)
Data Table on China - Market size and forecast 2024-2029 ($ billion)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ billion)
Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ billion)
Data Table on India - Market size and forecast 2024-2029 ($ billion)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ billion)
Data Table on France - Market size and forecast 2024-2029 ($ billion)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ billion)
Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
SWOT
15.5 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
15.6 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
SWOT
15.7 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
15.8 Cadila Pharmaceuticals Ltd.
Cadila Pharmaceuticals Ltd. - Overview
Cadila Pharmaceuticals Ltd. - Product / Service
Cadila Pharmaceuticals Ltd. - Key offerings
SWOT
15.9 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product / Service
Daiichi Sankyo Co. Ltd. - Key news
Daiichi Sankyo Co. Ltd. - Key offerings
SWOT
15.10 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key offerings
SWOT
15.11 Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. - Overview
Glenmark Pharmaceuticals Ltd. - Product / Service
Glenmark Pharmaceuticals Ltd. - Key offerings
SWOT
15.12 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
SWOT
15.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.14 Novo Nordisk AS
Novo Nordisk AS - Overview
Novo Nordisk AS - Business segments
Novo Nordisk AS - Key offerings
Novo Nordisk AS - Segment focus
SWOT
15.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15.17 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
SWOT
15.18 Tonghua Dongbao Pharmaceutical Co. Ltd.
Tonghua Dongbao Pharmaceutical Co. Ltd. - Overview
Tonghua Dongbao Pharmaceutical Co. Ltd. - Business segments
Tonghua Dongbao Pharmaceutical Co. Ltd. - Key offerings
Tonghua Dongbao Pharmaceutical Co. Ltd. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Market Segmentation by Delivery Mode
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Type 2 Diabetes Market 2019 - 2023 ($ billion)
Exhibits 26: Historic Market Size - Drug Class Segment 2019 - 2023 ($ billion)
Exhibits 27: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion)
Exhibits 28: Historic Market Size - Delivery Mode Segment 2019 - 2023 ($ billion)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Drug Class - Market share 2024-2029 (%)
Exhibits 39: Data Table on Drug Class - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Drug Class
Exhibits 41: Data Table on Comparison by Drug Class
Exhibits 42: Chart on Insulin - Market size and forecast 2024-2029 ($ billion)
Exhibits 43: Data Table on Insulin - Market size and forecast 2024-2029 ($ billion)
Exhibits 44: Chart on Insulin - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Insulin - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on DPP-4 inhibitor - Market size and forecast 2024-2029 ($ billion)
Exhibits 47: Data Table on DPP-4 inhibitor - Market size and forecast 2024-2029 ($ billion)
Exhibits 48: Chart on DPP-4 inhibitor - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on DPP-4 inhibitor - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on GLP-1 receptor agonists - Market size and forecast 2024-2029 ($ billion)
Exhibits 51: Data Table on GLP-1 receptor agonists - Market size and forecast 2024-2029 ($ billion)
Exhibits 52: Chart on GLP-1 receptor agonists - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on GLP-1 receptor agonists - Year-over-year growth 2024-2029 (%)
Exhibits 54: Chart on SGLT-2 inhibitors - Market size and forecast 2024-2029 ($ billion)
Exhibits 55: Data Table on SGLT-2 inhibitors - Market size and forecast 2024-2029 ($ billion)
Exhibits 56: Chart on SGLT-2 inhibitors - Year-over-year growth 2024-2029 (%)
Exhibits 57: Data Table on SGLT-2 inhibitors - Year-over-year growth 2024-2029 (%)
Exhibits 58: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 59: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 60: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 61: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 62: Market opportunity by Drug Class ($ billion)
Exhibits 63: Data Table on Market opportunity by Drug Class ($ billion)
Exhibits 64: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 65: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 66: Chart on Comparison by Distribution Channel
Exhibits 67: Data Table on Comparison by Distribution Channel
Exhibits 68: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ billion)
Exhibits 69: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ billion)
Exhibits 70: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 72: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ billion)
Exhibits 73: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ billion)
Exhibits 74: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 75: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 76: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ billion)
Exhibits 77: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ billion)
Exhibits 78: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 79: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 80: Market opportunity by Distribution Channel ($ billion)
Exhibits 81: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits 82: Chart on Delivery Mode - Market share 2024-2029 (%)
Exhibits 83: Data Table on Delivery Mode - Market share 2024-2029 (%)
Exhibits 84: Chart on Comparison by Delivery Mode
Exhibits 85: Data Table on Comparison by Delivery Mode
Exhibits 86: Chart on Oral - Market size and forecast 2024-2029 ($ billion)
Exhibits 87: Data Table on Oral - Market size and forecast 2024-2029 ($ billion)
Exhibits 88: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 90: Chart on Injectable - Market size and forecast 2024-2029 ($ billion)
Exhibits 91: Data Table on Injectable - Market size and forecast 2024-2029 ($ billion)
Exhibits 92: Chart on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits 93: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits 94: Chart on Continuous glucose monitoring (CGM) - Market size and forecast 2024-2029 ($ billion)
Exhibits 95: Data Table on Continuous glucose monitoring (CGM) - Market size and forecast 2024-2029 ($ billion)
Exhibits 96: Chart on Continuous glucose monitoring (CGM) - Year-over-year growth 2024-2029 (%)
Exhibits 97: Data Table on Continuous glucose monitoring (CGM) - Year-over-year growth 2024-2029 (%)
Exhibits 98: Market opportunity by Delivery Mode ($ billion)
Exhibits 99: Data Table on Market opportunity by Delivery Mode ($ billion)
Exhibits 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 101: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 102: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 103: Chart on Geographic comparison
Exhibits 104: Data Table on Geographic comparison
Exhibits 105: Chart on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits 106: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits 107: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits 110: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits 111: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits 114: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits 115: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits 118: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits 119: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 122: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 123: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits 126: Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits 127: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits 130: Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits 131: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on China - Market size and forecast 2024-2029 ($ billion)
Exhibits 134: Data Table on China - Market size and forecast 2024-2029 ($ billion)
Exhibits 135: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits 138: Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits 139: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on India - Market size and forecast 2024-2029 ($ billion)
Exhibits 142: Data Table on India - Market size and forecast 2024-2029 ($ billion)
Exhibits 143: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on France - Market size and forecast 2024-2029 ($ billion)
Exhibits 146: Data Table on France - Market size and forecast 2024-2029 ($ billion)
Exhibits 147: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits 150: Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits 151: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits 154: Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits 155: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 157: Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
Exhibits 158: Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
Exhibits 159: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 160: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 161: Market opportunity By Geographical Landscape ($ billion)
Exhibits 162: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 163: Impact of drivers and challenges in 2024 and 2029
Exhibits 164: Overview on criticality of inputs and factors of differentiation
Exhibits 165: Overview on factors of disruption
Exhibits 166: Impact of key risks on business
Exhibits 167: Companies covered
Exhibits 168: Company ranking index
Exhibits 169: Matrix on companies position and classification
Exhibits 170: Amgen Inc. - Overview
Exhibits 171: Amgen Inc. - Product / Service
Exhibits 172: Amgen Inc. - Key news
Exhibits 173: Amgen Inc. - Key offerings
Exhibits 174: SWOT
Exhibits 175: AstraZeneca Plc - Overview
Exhibits 176: AstraZeneca Plc - Product / Service
Exhibits 177: AstraZeneca Plc - Key news
Exhibits 178: AstraZeneca Plc - Key offerings
Exhibits 179: SWOT
Exhibits 180: Biocon Ltd. - Overview
Exhibits 181: Biocon Ltd. - Business segments
Exhibits 182: Biocon Ltd. - Key offerings
Exhibits 183: Biocon Ltd. - Segment focus
Exhibits 184: SWOT
Exhibits 185: Boehringer Ingelheim International GmbH - Overview
Exhibits 186: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 187: Boehringer Ingelheim International GmbH - Key news
Exhibits 188: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 189: SWOT
Exhibits 190: Cadila Pharmaceuticals Ltd. - Overview
Exhibits 191: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits 192: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits 193: SWOT
Exhibits 194: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 195: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits 196: Daiichi Sankyo Co. Ltd. - Key news

Executive Summary

The following companies are recognized as the key players in the global type 2 diabetes market: Amgen Inc., AstraZeneca Plc, Baxter International Inc., Biocon Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Daiichi Sankyo Co. Ltd., DM Pharma Marketing Pvt. Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Practo Technologies Pvt. Ltd., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Tonghua Dongbao Pharmaceutical Co. Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing geriatric population."

According to the report, one of the major drivers for this market is the rising prevalence of diabetes.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amgen Inc.
  • AstraZeneca Plc
  • Baxter International Inc.
  • Biocon Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Ltd.
  • Daiichi Sankyo Co. Ltd.
  • DM Pharma Marketing Pvt. Ltd.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • Johnson and Johnson Services Inc.
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • Practo Technologies Pvt. Ltd.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • Tonghua Dongbao Pharmaceutical Co. Ltd.

Related Topics

Related Reports

Antidiabetics Market Report 2024 - Product Image

Antidiabetics Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Antidiabetic Drugs Market by Type, Disease, Patient - Global Forecast 2025-2030 - Product Image

Antidiabetic Drugs Market by Type, Disease, Patient - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Antidiabetics Market by Product Type, by Application, by Distribution channel, and By Region - Product Image

Antidiabetics Market by Product Type, by Application, by Distribution channel, and By Region

  • Report
  • 200 Pages
  • Global
From
Antidiabetics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Image

Antidiabetics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • 183 Pages
  • Global
From
Antidiabetics Market Size, Share & Trends Analysis Report by Drug Class (GLP-1 Receptor Agonists, Insulin), Type (Type 1, Type 2), Route of Administration (Oral, Intravenous), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Antidiabetics Market Size, Share & Trends Analysis Report by Drug Class (GLP-1 Receptor Agonists, Insulin), Type (Type 1, Type 2), Route of Administration (Oral, Intravenous), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.